Bilateral Perisylvian Polymicrogyria

Bilateral perisylvian polymicrogyria is a brain development problem that starts before birth. In this condition, the brain area around the Sylvian fissures on both sides develops too many very small folds, and the normal layers of the brain cortex do not form in the usual way. Because this brain area helps with speech, mouth movement, swallowing, and many higher brain functions, children may have trouble with talking, chewing, swallowing, learning, movement, and seizures. It is a lifelong structural brain condition, not something a child “catches” after birth. [MedlinePlus Genetics] [NIH review].

Bilateral perisylvian polymicrogyria, often shortened to BPP, is a rare brain development disorder present from before birth. In this condition, the brain surface around the Sylvian fissures on both sides forms too many very small folds, and the normal brain layers do not organize in the usual way. Because this part of the brain helps control face, mouth, tongue, speech, swallowing, and some movement functions, many children develop seizures, drooling, chewing or swallowing trouble, slow speech development, and learning or movement problems. There is no cure that can reverse the abnormal brain structure, so treatment usually focuses on controlling symptoms, preventing complications, and improving daily function and quality of life. [15]

This condition is often discussed as part of a wider group called polymicrogyria. “Bilateral” means both sides of the brain are involved. “Perisylvian” means the area around the Sylvian fissure is mainly affected. “Polymicrogyria” means there are too many tiny brain folds. Bilateral forms usually cause more problems than mild one-sided forms, especially with seizures, development, speech, and swallowing. [MedlinePlus Genetics].

Other names

Bilateral perisylvian polymicrogyria is also called congenital bilateral perisylvian syndrome, bilateral perisylvian syndrome, and sometimes bilateral opercular or perisylvian syndrome in clinical writing. These names are used because the same brain region controls face, tongue, jaw, throat, speech, and swallowing functions, and many patients show a similar pattern of symptoms. [GARD] [NORD].

Types

• Classic bilateral perisylvian polymicrogyria (BPP): the abnormal folds are mainly limited to the perisylvian cortex on both sides. [NIH review].

• BPP plus extension (BPP+): the abnormal area starts around the Sylvian fissures but spreads beyond that nearby region. [NIH review].

• Asymmetric bilateral perisylvian polymicrogyria (ABPP): both sides are affected, but one side is more involved than the other. [NIH review].

• Mild partial perisylvian form: only part of the perisylvian region is involved, often with less severe problems. [NIH review].

• Severe perisylvian form: the whole perisylvian region is involved and the malformation may spread widely, usually causing more disability. [NIH review].

Causes

1. Unknown cause: many people with this condition never get one exact cause identified even after testing. Doctors still know it began during fetal brain development. [MedlinePlus Genetics].

2. General genetic change: some children have a harmful gene change that affects how the brain cortex grows, folds, and organizes before birth. [MedlinePlus Genetics] [NIH review].

3. PIK3R2 mutation: this is one of the best known genes linked to bilateral perisylvian polymicrogyria. It can increase growth signaling in the developing brain and lead to abnormal cortical folding. [MedlinePlus Genetics].

4. TUBA1A mutation: this gene helps brain cells move to the right place during development. When it is altered, abnormal brain folding and cortical malformations can happen. [NIH review].

5. NEDD4L mutation: this reported cause can disturb normal brain development and has been found in some people with polymicrogyria. [NIH review].

6. PIK3CA mutation: this gene is part of a brain growth pathway. A harmful variant may produce abnormal overgrowth or abnormal folding in the developing brain. [NIH review].

7. COL4A1 mutation: this gene can affect blood vessels and brain development. Problems in this gene may contribute to cortical injury or abnormal cortical formation. [NIH review].

8. COL4A2 mutation: like COL4A1, this gene can be linked to abnormal brain development and polymicrogyria in some patients. [NIH review].

9. GRIN2B mutation: this is another reported gene associated with polymicrogyria. It may affect brain signaling and development. [NIH review].

10. GPSM2 mutation: this gene has also been identified in some cases of polymicrogyria and may disturb normal brain patterning. [NIH review].

11. TUBB3 mutation: this gene helps make important cell structures needed for brain cell movement. Harmful variants can lead to cortical malformations. [NIH review].

12. WDR62 mutation: this reported cause can interfere with normal brain growth and cortical organization before birth. [NIH review].

13. TUBB2B mutation: this gene is important for neuronal migration, and mutations have been linked with polymicrogyria. [NIH review].

14. ACTG1 mutation: this less common reported gene can also be part of the genetic background of polymicrogyria. [NIH review].

15. FH mutation: this has been reported among causal genes in some polymicrogyria patients. [NIH review].

16. Chromosome deletion or rearrangement: sometimes a missing or rearranged piece of chromosome causes abnormal cortical development rather than a single-gene problem. [MedlinePlus Genetics].

17. 22q11.2 deletion syndrome: polymicrogyria, including perisylvian forms, has been reported in some people with this chromosome deletion syndrome. [MedlinePlus Genetics] [PubMed].

18. Congenital cytomegalovirus infection: CMV infection during pregnancy is a well-known non-genetic cause of polymicrogyria, especially when it damages the developing fetal brain. [MedlinePlus Genetics] [NIH review].

19. Other congenital infections: toxoplasmosis, varicella, and similar prenatal infections have been reported as acquired causes of polymicrogyria because they can injure the fetal cortex. [Case review] [Review].

20. Reduced oxygen or blood flow before birth: intrauterine ischemia, prenatal stroke, or blood-flow problems in monochorionic twin pregnancy can injure the developing cortex and lead to polymicrogyria. [MedlinePlus Genetics] [Prenatal MRI report].

Symptoms

1. Seizures: epilepsy is one of the most common problems. Seizures may start in infancy or childhood, and some children need long-term treatment. [MedlinePlus Genetics] [NIH cohort].

2. Developmental delay: a child may sit, stand, walk, or learn later than expected because the brain network did not develop in the usual way. [MedlinePlus Genetics] [NIH cohort].

3. Speech delay: many children are late to start speaking or have very limited speech because the perisylvian area is important for speech output. [Systematic review] [GARD].

4. Language difficulty: some children understand less language than expected, while others understand better than they can speak. Language trouble can range from mild to severe. [Systematic review].

5. Swallowing difficulty: dysphagia is common because the face, tongue, jaw, and throat muscles may not work together well. [GARD] [NORD].

6. Chewing difficulty: children may struggle to bite, chew, or move food in the mouth because oral motor control is poor. [NORD] [Case report].

7. Heavy drooling: poor mouth and tongue control can make saliva control difficult, so drooling is common. [GARD] [Case report].

8. Slurred or unclear speech: this happens when tongue, lip, jaw, and throat movement is weak or poorly coordinated. Doctors may call this dysarthria. [MedGen] [StatPearls].

9. Facial weakness: the child may have reduced movement of the face, especially around the mouth, because of pseudobulbar dysfunction. [GARD] [NORD].

10. Tongue movement problem: the tongue may not stick out well or move side to side normally, which affects speech and eating. [Case report] [GARD].

11. Learning difficulty or intellectual disability: thinking and school performance may be below age level, although severity varies from mild to severe. [GARD] [NIH cohort].

12. Muscle weakness or spasticity: some children have stiffness, weakness, or poor motor control in the arms and legs, especially in bilateral forms. [MedlinePlus Genetics] [NIH cohort].

13. Crossed eyes: some patients have strabismus, where the eyes do not line up normally. [MedlinePlus Genetics].

14. Poor feeding in infancy: babies may take a long time to feed, choke easily, or fail to coordinate sucking and swallowing. [Case report] [NORD].

15. Behavioral or social difficulties: some children have frustration, communication problems, or behavior issues related to language and cognitive difficulty. [Contact] [Systematic review].

Diagnostic tests

The diagnosis is built from history, examination, brain imaging, and cause-finding tests. MRI is the key test, while EEG, speech and swallowing assessment, and genetic work-up help define the full problem. [NIH review].

1. General physical examination: the doctor checks growth, head size, feeding status, muscle tone, and visible birth differences. This helps show how much the condition affects the whole child. [NIH cohort] [GARD].

2. Detailed neurological examination: the doctor tests alertness, reflexes, muscle tone, strength, coordination, and developmental signs. This helps show brain and nerve function. [NIH cohort].

3. Cranial nerve examination: this is very important because the condition often affects the face, tongue, jaw, and throat. The doctor checks facial movement, gag, tongue motion, speech, and swallowing safety. [GARD] [MedGen].

4. Developmental assessment: this checks milestones such as sitting, walking, understanding, speaking, and daily skills. It helps measure delay and plan therapy. [MedlinePlus Genetics] [NIH cohort].

5. Speech-language assessment: a speech-language specialist checks speech sounds, language understanding, language expression, and oral motor control. This is a major test in this condition. [Systematic review].

6. Oral motor examination: this manual bedside test checks lip closure, tongue movement, jaw control, drooling, and mouth coordination. It helps explain feeding and speech problems. [Systematic review] [Case report].

7. Swallowing clinical evaluation: the clinician watches how the child swallows liquids and foods, and looks for choking, coughing, wet voice, or food pocketing. [NORD] [Case report].

8. Feeding assessment: especially in babies and small children, feeding specialists assess sucking, chewing, coordination, and calorie intake. This helps prevent poor growth and aspiration. [Case report] [NORD].

9. Neuropsychological or cognitive testing: these tests check memory, attention, learning, reasoning, and school-related abilities. They help measure intellectual impact. [Sciencedirect abstract] [NIH cohort].

10. Electroencephalogram (EEG): EEG records brain electrical activity and helps confirm seizures, classify seizure type, and guide treatment. [NIH review].

11. Video EEG monitoring: when seizures are hard to understand, longer EEG with video can connect body movements with brain activity more clearly. This is often used in epilepsy work-up. [Epilepsy literature] [NIH review].

12. Brain MRI: this is the most important imaging test. It shows the abnormal cortex, where it is located, and how severe it is. [NIH review].

13. High-resolution epilepsy-protocol MRI: thin-slice MRI gives a clearer view of the tiny abnormal folds and nearby structures, which is very useful in cortical malformations. [NIH cohort] [EpilepsyDiagnosis].

14. T1-weighted MRI sequences: these help show cortical shape and apparent thickening around the Sylvian fissures. [MRI references].

15. T2-weighted and FLAIR MRI sequences: these help show the irregular cortical surface, stippled gray-white border, and any white matter signal change. [NIH cohort] [EpilepsyDiagnosis].

16. CT scan of the brain: CT is less sensitive than MRI for polymicrogyria, but it may still be used when MRI is not available or when calcification is being considered. [Case report].

17. Genetic testing panel: multigene testing can look for known polymicrogyria genes such as PIK3R2, TUBA1A, and others. This can help explain why the condition happened. [NIH review].

18. Chromosomal microarray or chromosome analysis: these tests look for missing or extra chromosome pieces, such as 22q11.2 deletion, that may be linked with polymicrogyria. [MedlinePlus Genetics] [PubMed].

19. Infection testing when suspected: if the history suggests a prenatal infection, doctors may order tests for congenital CMV or other infections because these are known non-genetic causes. [MedlinePlus Genetics] [Review].

20. Pathological examination of brain tissue: this is not a routine test for most children, but in rare situations such as surgery or autopsy, pathology can confirm abnormal cortical layering and too many small folds. [NIH cohort] [Pathology review].

Non-Pharmacological Treatments

1) Regular pediatric neurology follow-up. This is the core treatment plan because BPP changes over time. The purpose is to watch seizures, development, feeding, tone, and school progress. The mechanism is simple: repeated assessment helps doctors change medicines, order EEG or MRI when needed, and send the child early to therapy services before disability becomes worse.

2) Speech therapy. Many children with BPP have dysarthria, limited speech, or delayed language. Speech therapy helps the child make sounds more clearly, use words better, and communicate needs. Its mechanism is repeated practice of breath support, mouth control, sound production, word use, and caregiver coaching. Systematic review data show speech, language, and oral function problems are very common in BPP.

3) Language therapy and communication training. Some children understand more than they can say. The purpose is to improve both expressive and receptive language. The mechanism is step-by-step language stimulation, naming practice, sentence building, picture use, and social communication work. This can reduce frustration and help school participation.

4) Augmentative and alternative communication, such as picture boards or speech devices. This is helpful when speech is very limited. The purpose is to give the child a reliable way to communicate. The mechanism is bypassing weak oral speech and using symbols, touch, or device-based speech output. It often improves independence and family interaction.

5) Oral-motor therapy. Because BPP often affects mouth and tongue control, oral-motor work can help lip closure, chewing pattern, drooling control, and safe swallowing. The purpose is better mouth function. The mechanism is guided exercises and sensory-motor practice for lips, tongue, jaw, and face. Evidence from children with neurologic oral dysfunction supports benefit for oral function.

6) Swallowing therapy by a speech-swallow specialist. This is very important when coughing during meals, choking, wet voice, slow eating, or poor weight gain is present. The purpose is safer swallowing and less aspiration risk. The mechanism includes swallow assessment, posture changes, pacing, bolus control, and caregiver training.

7) Texture-modified food and thickened liquids when prescribed. Softer foods or thickened liquids may be needed if thin liquids or hard solids are unsafe. The purpose is to reduce choking and aspiration. The mechanism is easier oral control and slower movement of food, giving the child more time to coordinate swallowing.

8) Feeding-position therapy. Upright posture during and after meals can improve swallowing safety. The purpose is to lower aspiration risk and make feeding more efficient. The mechanism is using gravity and better head-neck alignment so food moves more safely through the mouth and throat.

9) Physical therapy. Some children have weakness, stiffness, balance problems, or delayed motor milestones. The purpose is better sitting, standing, walking, and overall mobility. The mechanism is repeated guided movement, stretching, strengthening, balance work, and gait training.

10) Occupational therapy. This helps hand use, feeding skills, dressing, posture, sensory issues, and daily living tasks. The purpose is more independence. The mechanism is task-specific practice and adaptive strategies that make daily routines easier and safer.

11) Early intervention services. In infants and toddlers, early therapy often improves later function. The purpose is to start help before delays become deeply established. The mechanism is early brain and behavior training during fast development.

12) Special education and individualized school support. Some children need adapted teaching, extra speech services, or classroom support. The purpose is better learning and participation. The mechanism is matching education to the child’s language, motor, and cognitive level.

13) Seizure action plan for home and school. This includes what to do during a seizure, when to give rescue medicine, and when to call emergency care. The purpose is safety. The mechanism is rapid, organized response that reduces treatment delay and confusion.

14) Home safety changes. Padded sharp edges, supervised bathing, safer stairs, helmet use in selected cases, and sleep safety may be needed. The purpose is injury prevention. The mechanism is reducing the physical harm that can happen during sudden seizures or falls.

15) Sleep hygiene. Poor sleep can worsen seizures and daytime function. The purpose is to improve seizure control and behavior. The mechanism is regular sleep timing, quiet sleep environment, and treatment of sleep-disordered breathing if present.

16) Nutrition review with a dietitian. Feeding problems can lead to low calorie intake, low protein intake, and micronutrient deficits. The purpose is healthy growth and stronger recovery. The mechanism is measured nutrition planning matched to swallowing safety and energy needs.

17) Dental and oral care. Drooling, open-mouth posture, and feeding difficulties can raise the risk of dental disease. The purpose is mouth health and comfort. The mechanism is regular cleaning, saliva management, and dental review.

18) Caregiver training. Parents and family need training in feeding safety, therapy carryover, medicine timing, and seizure first aid. The purpose is better day-to-day care. The mechanism is consistent home practice and faster recognition of red-flag symptoms.

19) Psychological and behavior support. Chronic neurologic disease can cause stress, frustration, and family burden. The purpose is emotional health and better coping. The mechanism is counseling, behavior plans, and family support.

20) Genetic counseling. Some forms of polymicrogyria are linked to genetic causes. The purpose is to understand cause, recurrence risk, and family planning. The mechanism is careful review of imaging, clinical findings, and genetic test results.

Drug Treatments

There is no FDA-approved drug that cures BPP itself. Medicines are used mainly for seizures, drooling, muscle stiffness, or emergency seizure control. The exact dose must be chosen by the treating neurologist because age, weight, seizure type, liver function, kidney function, and drug interactions matter.

1) Levetiracetam. Class: antiseizure drug. FDA labels support use in several seizure types. A common starting pattern is low-dose twice daily, then slow increase by doctor guidance. Purpose: reduce seizure frequency. Mechanism: it binds SV2A and changes neurotransmitter release. Side effects can include sleepiness, irritability, and behavioral change.

2) Clobazam. Class: benzodiazepine antiseizure medicine. It is often used when seizures are hard to control. Dose is individualized and usually increased slowly. Purpose: lower seizure burden. Mechanism: it enhances GABA signaling and calms abnormal firing. Side effects include sleepiness, drooling, constipation, and dependence risk with long use.

3) Divalproex or valproic acid. Class: broad-spectrum antiseizure drug. Dose is often weight-based and titrated carefully. Purpose: control generalized or mixed seizure patterns. Mechanism: raises inhibitory signaling and affects sodium and calcium pathways. Side effects include liver toxicity risk, pancreatitis risk, weight gain, tremor, and major fetal risk in pregnancy.

4) Lamotrigine. Class: antiseizure drug. It must be started slowly because rash risk increases with rapid titration. Purpose: reduce focal and generalized seizures in selected patients. Mechanism: blocks voltage-sensitive sodium channels and reduces excitatory release. Side effects include rash, dizziness, double vision, and rare life-threatening skin reactions.

5) Oxcarbazepine. Class: antiseizure drug. It is used for focal seizure control and dosing is usually twice daily with slow adjustment. Purpose: reduce seizure activity. Mechanism: stabilizes sodium channels. Side effects include dizziness, double vision, sleepiness, rash, and low sodium.

6) Carbamazepine. Class: antiseizure drug. Purpose: focal seizure control in selected patients. Mechanism: sodium-channel blockade reduces repeated firing. Side effects include dizziness, sleepiness, liver issues, blood count problems, rash, and serious skin reactions in higher-risk genetic groups.

7) Lacosamide. Class: antiseizure drug. It is often added when one medicine is not enough. Purpose: lower focal seizure frequency. Mechanism: enhances slow inactivation of sodium channels. Side effects include dizziness, nausea, and PR-interval prolongation in some patients.

8) Topiramate. Class: broad-spectrum antiseizure drug. Purpose: help control focal or generalized seizures. Mechanism: multiple actions including sodium-channel effects and GABA support. Side effects include sleepiness, slow thinking, weight loss, kidney stone risk, and reduced sweating in some children.

9) Clonazepam. Class: benzodiazepine. Purpose: adjunct seizure control in some patients. Mechanism: boosts GABA activity and calms neuronal firing. Side effects include sedation, drooling, coordination problems, tolerance, and withdrawal risk if stopped suddenly.

10) Diazepam rectal gel. Class: rescue benzodiazepine. It is not for daily prevention. Purpose: stop a seizure cluster at home or school when prescribed. Mechanism: rapid GABA enhancement. Side effects include sleepiness and breathing suppression risk, especially with other sedatives.

11) Midazolam nasal spray. Class: rescue benzodiazepine. Purpose: treat seizure clusters quickly without rectal dosing. Mechanism: rapid nasal absorption and GABA enhancement. Side effects include sedation, nasal discomfort, and breathing risk with overdose or other sedatives.

12) Diazepam nasal spray. Class: rescue benzodiazepine. Purpose: emergency outpatient treatment of seizure clusters. Mechanism: fast benzodiazepine action through nasal delivery. Side effects are similar to other benzodiazepines.

13) Brivaracetam. Class: antiseizure drug related to levetiracetam. Purpose: adjunct seizure control. Mechanism: high-affinity SV2A binding. Side effects include sleepiness, dizziness, fatigue, and mood changes.

14) Perampanel. Class: antiseizure drug. Purpose: adjunct control of focal or primary generalized tonic-clonic seizures in appropriate ages. Mechanism: AMPA receptor antagonism reduces excitatory signaling. Side effects can include dizziness, sleepiness, falls, and important psychiatric or behavioral reactions.

15) Rufinamide. Class: antiseizure drug. Purpose: helpful mainly in seizure patterns similar to Lennox-Gastaut syndrome. Mechanism: affects sodium-channel activity and stabilizes firing. Side effects include sleepiness, nausea, shorter QT interval, and interaction with valproate.

16) Cannabidiol oral solution. Class: plant-derived antiseizure medicine. Purpose: approved for certain severe epilepsy syndromes, not specifically BPP, but sometimes considered when syndrome overlap exists. Mechanism is not fully understood. Side effects include sleepiness, diarrhea, poor appetite, and liver enzyme elevation.

17) Baclofen. Class: antispastic drug. Purpose: reduce painful stiffness or spasm if tone problems are significant. Mechanism: GABA-B receptor action in the spinal cord reduces muscle spasm. Side effects include weakness, sleepiness, and overdose or withdrawal risk if used improperly.

18) Glycopyrrolate oral solution. Class: anticholinergic. Purpose: treat severe chronic drooling in neurologically impaired children. Mechanism: lowers saliva production. Side effects include constipation, flushing, urinary retention, and thick secretions.

19) OnabotulinumtoxinA. Class: neurotoxin injection. Purpose: focal spasticity treatment in selected patients, not a cure for BPP. Mechanism: blocks acetylcholine release at the neuromuscular junction. Side effects include local weakness and, in higher-risk patients, swallowing or breathing problems.

20) Gabapentin. Class: antiseizure drug, though now used more often for pain than epilepsy. It may still be considered in selected cases by specialists. Mechanism: binds calcium-channel subunits and reduces excitatory release. Side effects include dizziness, sleepiness, and behavior change.

Dietary Molecular Supplements

These supplements do not correct the brain malformation. They may help only when there is poor intake, drug-related nutrient loss, or a proven deficiency. Doses should be individualized by a clinician.

Vitamin D, calcium, magnesium, vitamin B6, vitamin B12, folate, zinc, iron, omega-3 fatty acids, and protein-calorie oral nutrition formulas are the most practical nutrition supports in children with neurologic feeding problems. Their purpose is to support bone health, nerve and muscle function, red blood cell formation, growth, and better overall nutrition. Their mechanisms differ: vitamin D and calcium support bone mineralization; magnesium and B vitamins support enzyme and nerve function; iron supports oxygen transport; zinc supports growth and healing; omega-3 fatty acids are structural fats in cell membranes; and oral nutrition formulas improve calorie and protein intake when chewing or swallowing is limited. These are helpful only when matched to a real nutritional need.

Immunity Booster, Regenerative, or Stem Cell Drugs

There are no FDA-approved immunity-booster drugs, regenerative drugs, or stem-cell drugs specifically for bilateral perisylvian polymicrogyria. At present, evidence-based care focuses on seizure control, rehabilitation, feeding safety, and surgery for selected drug-resistant epilepsy cases. Because BPP is a structural malformation of cortical development, unproven “brain regeneration” or “stem cell cure” claims should be treated very carefully.

Surgeries

1) Focal resection or tailored epilepsy surgery. This is done when seizures are drug-resistant and testing shows a removable seizure focus. It is done to reduce seizures or achieve seizure freedom in selected patients.

2) Corpus callosotomy. This palliative surgery disconnects the two brain hemispheres partly or fully to reduce dangerous drop attacks and some generalized seizure spread. It is considered when medicines fail and seizures cause repeated injury.

3) Vagus nerve stimulation. This is an implanted device, not brain tissue removal. It is done when seizures remain uncontrolled and resection is not suitable. It helps by delivering intermittent vagus nerve stimulation that can reduce seizure burden over time.

4) Responsive neurostimulation in selected older patients. This is considered in special refractory epilepsy cases. It is done to detect and interrupt abnormal electrical activity. It is not standard for every child with BPP.

5) Gastrostomy tube placement. This is done when swallowing is unsafe, feeding takes too long, weight gain is poor, or aspiration risk is high. It is done to provide safe nutrition, hydration, and medicine delivery.

Preventions

BPP itself usually cannot be prevented after it has formed before birth, but complications can often be reduced. Good prevention steps are: regular seizure follow-up, strict medicine adherence, rescue-medicine access, aspiration prevention during feeding, vaccine and infection prevention as advised, good sleep, nutrition monitoring, fall-proof home setup, dental care, and early therapy referral when new delays appear. These steps help prevent injuries, malnutrition, pneumonia, and avoidable functional decline.

When to See Doctors

Seek medical care quickly if there is a first seizure, longer seizure, repeated seizure cluster, blue color, breathing trouble, new choking, weight loss, dehydration, repeated chest infection, marked sleepiness, loss of skills, severe behavior change, or sudden weakness. Emergency care is especially important for a seizure lasting longer than the time given in the child’s seizure plan, for repeated seizures without recovery, or when rescue medicine does not work.

What to Eat and What to Avoid

Better choices are soft balanced foods that match swallow safety, high-protein foods, calorie-dense foods when growth is low, iron-rich foods, zinc-rich foods, vitamin D and calcium sources, fruit and vegetables, adequate fluids if safe, dietitian-approved nutrition formulas, and texture-adjusted meals. Foods to avoid depend on the swallow test, but common unsafe items include thin liquids if aspirated, dry crumbly foods, hard nuts, large tough meat pieces, sticky foods, and any food that repeatedly causes choking. Avoid random supplements, herbal “brain cures,” or unproven stem-cell products without specialist review.

FAQs

What is BPP? It is a rare malformation of brain development around both Sylvian fissures.

Is it present from birth? Yes. The abnormal brain folding develops before birth.

Is there a cure? No cure is known at present. Treatment is supportive and symptom-based.

Are seizures common? Yes, seizures are common, though severity varies.

Does every child have intellectual disability? No. Severity varies from mild to severe.

Why are speech problems so common? The perisylvian region helps control mouth, tongue, and language functions.

Can swallowing problems happen? Yes. Drooling, chewing difficulty, and aspiration can occur.

Can children walk? Some can walk well, some need therapy or support, and some are more impaired.

Is surgery ever useful? Yes, especially in selected drug-resistant epilepsy cases.

Can medicines cure the brain malformation? No. Medicines treat symptoms such as seizures or spasticity.

Are stem-cell drugs proven? No. There is no approved stem-cell cure for BPP.

Should all children get genetic testing? Many benefit from specialist review because some cases have genetic causes.

Can BPP get worse with age? The malformation itself does not reverse, but symptoms and needs can change over time.

Can adults have BPP? Yes. Children grow into adults with BPP.

What helps most in daily life? Usually the biggest gains come from good seizure control, early speech and feeding therapy, nutrition support, and caregiver training.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: March 10, 2025.